Have a feature idea you'd love to see implemented?
Let us know!
MNMD Mind Medicine (MindMed) Inc
Price (delayed)
$7.09
Market cap
$519.92M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.99
Enterprise value
$248.95M
Highlights
Mind Medicine (MindMed)'s equity has soared by 173% YoY and by 30% from the previous quarter
MNMD's quick ratio has soared by 135% YoY and by 53% from the previous quarter
The net income has declined by 27% year-on-year but it is up by 4.2% since the previous quarter
The company's EPS rose by 12% QoQ but it fell by 6% YoY
The debt has surged by 73% year-on-year
Key stats
What are the main financial stats of MNMD
Market
Valuations
Earnings
Shares outstanding
73.33M
Market cap
$519.92M
Enterprise value
$248.95M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.95
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$96.18M
EBITDA
-$94.86M
Free cash flow
-$74.34M
Per share
Balance sheet
Liquidity
EPS
-$1.99
Free cash flow per share
-$0.95
Book value per share
$3.63
Revenue per share
$0
TBVPS
$3.85
Total assets
$319.77M
Total liabilities
$57.58M
Debt
$24.31M
Equity
$262.19M
Working capital
$266.09M
Debt to equity
0.09
Current ratio
9
Quick ratio
8.88
Net debt/EBITDA
2.86
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-39.6%
Return on equity
-53%
Return on invested capital
N/A
Return on capital employed
-33.6%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
MNMD stock price
How has the Mind Medicine (MindMed) stock price performed over time
Intraday
-5.72%
1 week
-15.49%
1 month
9.41%
1 year
164.55%
YTD
93.72%
QTD
24.6%
Financial performance
How have Mind Medicine (MindMed)'s revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$93.66M
Net income
-$97.8M
Gross margin
N/A
Net margin
N/A
The net income has declined by 27% year-on-year but it is up by 4.2% since the previous quarter
The operating income has declined by 9% year-on-year and by 3.5% since the previous quarter
Growth
What is Mind Medicine (MindMed)'s growth rate over time
Valuation
What is Mind Medicine (MindMed) stock price valuation
P/E
N/A
P/B
1.95
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The company's EPS rose by 12% QoQ but it fell by 6% YoY
Mind Medicine (MindMed)'s equity has soared by 173% YoY and by 30% from the previous quarter
The P/B is 39% below the 5-year quarterly average of 3.2 and 2.5% below the last 4 quarters average of 2.0
Efficiency
How efficient is Mind Medicine (MindMed) business performance
The ROE is up by 26% since the previous quarter and by 17% year-on-year
MNMD's ROA is up by 21% from the previous quarter and by 21% YoY
Dividends
What is MNMD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for MNMD.
Financial health
How did Mind Medicine (MindMed) financials performed over time
MNMD's quick ratio has soared by 135% YoY and by 53% from the previous quarter
The company's current ratio has surged by 134% YoY and by 52% QoQ
The debt is 91% smaller than the equity
Mind Medicine (MindMed)'s equity has soared by 173% YoY and by 30% from the previous quarter
The debt has surged by 73% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.